Benzodiazepines and Opioid co-use Among Rural People Who Use Drugs: Findings From the Rural Opioid Initiative.

L Sarah Mixson, Arvind Venkataraman, Lydia N Drumright, Bridget M Whitney, Wiley D Jenkins, Peter D Friedmann, William A Zule, Jennifer Havens, Stephanie A Ruderman, Thomas J Stopka, P Todd Korthuis, Mai T Pho, Ryan P Westergaard, David W Seal, Vivian F Go, William C Miller, Judith Feinberg, Gordon Smith, Judith I Tsui, Joseph A Delaney, Heidi M Crane
{"title":"Benzodiazepines and Opioid co-use Among Rural People Who Use Drugs: Findings From the Rural Opioid Initiative.","authors":"L Sarah Mixson, Arvind Venkataraman, Lydia N Drumright, Bridget M Whitney, Wiley D Jenkins, Peter D Friedmann, William A Zule, Jennifer Havens, Stephanie A Ruderman, Thomas J Stopka, P Todd Korthuis, Mai T Pho, Ryan P Westergaard, David W Seal, Vivian F Go, William C Miller, Judith Feinberg, Gordon Smith, Judith I Tsui, Joseph A Delaney, Heidi M Crane","doi":"10.1177/29767342251331701","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Benzodiazepines and opioids are among the most frequently misused psychoactive substances, but their patterns of co-use (polysubstance use) in rural areas are unclear. As resources to address substance use are disproportionally scarce in rural areas, a better understanding of this polysubstance use is critical to allocate and direct interventions.</p><p><strong>Methods: </strong>The Rural Opioid Initiative comprises 8 research cohorts spanning 10 states and 65 rural counties. Participants were recruited from January 2018 to March 2020 and eligibility included past 30-day opioid use by any route or past 30-day injection of any substance. Analyses were restricted to participants reporting past 30-day opioid use and either benzodiazepine or stimulant use. We described bivariate cross-sectional associations between benzodiazepine+opioid use, compared with stimulant+opioid use, and substance use behaviors, health outcomes, injection drug use, addiction treatment, and criminal legal system involvement.</p><p><strong>Results: </strong>Of the 1107 ROI participants that met inclusion criteria, 10% (n = 107) reported benzodiazepine+opioid use, and 90% (n = 1000) reported stimulant+opioid use. The benzodiazepine+opioid group, compared with the stimulant+opioid group, had a higher use of opioid pain medication (73% vs 55%), gabapentin (43% vs 23%), and clonidine (12% vs 4%) to get high and used these substances more frequently; they also reported more frequent heavy episodic drinking (6.1 days per 30 days, SD = 9.4 vs 4.1 days, SD 7.5). The benzodiazepine+opioid group reported a lower prevalence in the past 6 months of law enforcement stop-and-search incidents (29% vs 48%), arrests (11% vs 28%), probation (22% vs 34%), jail/prison (18% vs 41%), and fewer days in jail/prison (4.7, SD = 19.1 days vs 15.9, SD = 35.7 days).</p><p><strong>Conclusion: </strong>We found that benzodiazepines+opioids use was associated with more heavy episodic drinking and gabapentin use, and lower prevalence of criminal legal system involvement. These data suggest that individuals reporting benzodiazepines+opioids use have distinct behavioral patterns and outcomes that require targeted interventions for rural populations.</p>","PeriodicalId":516535,"journal":{"name":"Substance use & addiction journal","volume":" ","pages":"29767342251331701"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance use & addiction journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/29767342251331701","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Benzodiazepines and opioids are among the most frequently misused psychoactive substances, but their patterns of co-use (polysubstance use) in rural areas are unclear. As resources to address substance use are disproportionally scarce in rural areas, a better understanding of this polysubstance use is critical to allocate and direct interventions.

Methods: The Rural Opioid Initiative comprises 8 research cohorts spanning 10 states and 65 rural counties. Participants were recruited from January 2018 to March 2020 and eligibility included past 30-day opioid use by any route or past 30-day injection of any substance. Analyses were restricted to participants reporting past 30-day opioid use and either benzodiazepine or stimulant use. We described bivariate cross-sectional associations between benzodiazepine+opioid use, compared with stimulant+opioid use, and substance use behaviors, health outcomes, injection drug use, addiction treatment, and criminal legal system involvement.

Results: Of the 1107 ROI participants that met inclusion criteria, 10% (n = 107) reported benzodiazepine+opioid use, and 90% (n = 1000) reported stimulant+opioid use. The benzodiazepine+opioid group, compared with the stimulant+opioid group, had a higher use of opioid pain medication (73% vs 55%), gabapentin (43% vs 23%), and clonidine (12% vs 4%) to get high and used these substances more frequently; they also reported more frequent heavy episodic drinking (6.1 days per 30 days, SD = 9.4 vs 4.1 days, SD 7.5). The benzodiazepine+opioid group reported a lower prevalence in the past 6 months of law enforcement stop-and-search incidents (29% vs 48%), arrests (11% vs 28%), probation (22% vs 34%), jail/prison (18% vs 41%), and fewer days in jail/prison (4.7, SD = 19.1 days vs 15.9, SD = 35.7 days).

Conclusion: We found that benzodiazepines+opioids use was associated with more heavy episodic drinking and gabapentin use, and lower prevalence of criminal legal system involvement. These data suggest that individuals reporting benzodiazepines+opioids use have distinct behavioral patterns and outcomes that require targeted interventions for rural populations.

苯二氮卓类药物和阿片类药物在农村吸毒人群中的共同使用:来自农村阿片类药物倡议的发现。
背景:苯二氮卓类药物和阿片类药物是最常被滥用的精神活性物质,但它们在农村地区的共同使用模式(多物质使用)尚不清楚。由于农村地区用于解决药物使用问题的资源极其稀缺,因此更好地了解这种多物质使用情况对于分配和指导干预措施至关重要。方法:农村阿片类药物倡议包括8个研究队列,横跨10个州和65个农村县。参与者于2018年1月至2020年3月招募,资格包括过去30天以任何途径使用阿片类药物或过去30天注射任何物质。分析仅限于报告过去30天使用阿片类药物和苯二氮卓类药物或兴奋剂的参与者。我们描述了苯二氮卓类药物+阿片类药物使用与兴奋剂+阿片类药物使用、物质使用行为、健康结果、注射药物使用、成瘾治疗和刑事法律系统参与之间的双变量横断面关联。结果:在1107名符合纳入标准的ROI参与者中,10% (n = 107)报告了苯二氮卓类药物+阿片类药物的使用,90% (n = 1000)报告了兴奋剂+阿片类药物的使用。与兴奋剂+阿片类药物组相比,苯二氮卓类药物+阿片类药物组使用阿片类止痛药(73%对55%)、加巴喷丁(43%对23%)和克拉定(12%对4%)来获得快感,并且使用这些物质的频率更高;他们还报告了更频繁的重度间歇性饮酒(每30天6.1天,SD = 9.4 vs 4.1天,SD 7.5)。苯二氮卓类药物+阿片类药物组在过去6个月的执法拦截和搜查事件(29%对48%)、逮捕(11%对28%)、缓刑(22%对34%)、监狱/监狱(18%对41%)的发生率较低,并且在监狱/监狱的时间较短(4.7天,SD = 19.1天对15.9天,SD = 35.7天)。结论:我们发现苯二氮卓类药物+阿片类药物的使用与更严重的间歇性饮酒和加巴喷丁的使用有关,并且刑事司法系统介入的发生率较低。这些数据表明,报告使用苯二氮卓类药物+阿片类药物的个人具有不同的行为模式和结果,需要对农村人口进行有针对性的干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信